University of the State of Amazonas, Manaus, Brazil.
Blood Center of the Amazon State, HEMOAM, Manaus, Brazil.
Malar J. 2019 Aug 27;18(1):289. doi: 10.1186/s12936-019-2918-4.
The Duffy glycoprotein acts as the entry point for merozoites of Plasmodium vivax in the invasion of red blood cells. The host-parasite relationship has revealed new perspectives regarding the association between Duffy polymorphisms that can impact both the parasite density of this Plasmodium and the symptoms of this type of malaria. This study investigates the impact of Duffy polymorphisms on parasite density in patients infected with P. vivax in the Brazilian Amazon region.
Genotypes and Duffy polymorphism allele frequencies were compared in 287 patients with malaria, presenting low, medium and high density of P. vivax. The diagnosis of malaria was performed using a specialized team with a standardized clinical-laboratory method, while the Duffy genotyping was performed through the Bead Chip BioArray system. Both teams are reference services in Brazil.
The FY01 and FY02 alleles were found in all three parasite density classes: low, medium and high, but when these alleles form genotypes with FY02N.01 and FY02W.01 alleles, they are found only in patients with low parasite density and low symptomatology. Another interesting finding found in this study is the presence of the genotype FY02N.01/FY02W.01 in one of the patients, presenting a very low parasite density and malaria considered subclinical, a genotype which had not been previously described in the literature.
The presence of FY02N.01 and FY02W.01 alleles may have an impact on the reduction of clinical manifestations in malaria, leading to the development of subclinical malaria, making the infected individual an undetected natural reservoir, which may hinder the eradication of malaria in the Amazon.
达菲糖蛋白是间日疟原虫进入红细胞入侵的切入点。宿主-寄生虫关系揭示了新的观点,即达菲多态性的关联可以影响这种疟原虫的寄生虫密度和这种疟疾的症状。本研究调查了达菲多态性对巴西亚马逊地区感染间日疟原虫患者寄生虫密度的影响。
在 287 例疟疾患者中比较了基因型和达菲多态性等位基因频率,这些患者的间日疟原虫密度低、中、高。疟疾的诊断是由一个具有标准化临床-实验室方法的专门小组进行的,而达菲基因分型是通过珠芯生物芯片系统进行的。这两个团队都是巴西的参考服务。
FY01 和 FY02 等位基因在低、中、高三种寄生虫密度中均有发现,但当这些等位基因与 FY02N.01 和 FY02W.01 等位基因形成基因型时,它们只存在于低寄生虫密度和低症状的患者中。本研究的另一个有趣发现是,在一名患者中存在 FY02N.01/FY02W.01 基因型,该患者的寄生虫密度极低,疟疾被认为是亚临床的,这种基因型以前在文献中没有描述过。
FY02N.01 和 FY02W.01 等位基因的存在可能会影响疟疾临床表现的减轻,导致亚临床疟疾的发展,使感染个体成为未被发现的自然储主,这可能会阻碍亚马逊地区疟疾的根除。